Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 10:48 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2185–2208 of 121,474 matching trials from the live ClinicalTrials.gov search.

Filters: Completed Clear all

Conditions: Post Herpetic Neuralgia
Interventions: NXN-462, Placebo; Drug
Lead sponsor: NeurAxon Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 188 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 22
States / cities: Phoenix, Arizona • Los Angeles, California • Sacramento, California + 19 more

Conditions: Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma, High Grade Glioma
Interventions: CAN-2409, Valacyclovir, Temozolomide, Radiation therapy; Biological · Drug · Radiation
Lead sponsor: Candel Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2016
U.S. locations: 4
States / cities: Duarte, California • Chicago, Illinois • Columbus, Ohio + 1 more

Conditions: Depressive Disorder
Interventions: duloxetine; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: Stanford, California

Conditions: Stroke Hemorrhagic, Depression
Interventions: Fluoxetine, Placebo; Drug
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 85 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Type 2 Diabetes, Diabetes
Interventions: Diabetes Self Management Program; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Stanford, California

Conditions: Bacterial Infections
Interventions: ceftaroline, vancomycin plus aztreonam, Placebo; Drug
Lead sponsor: Forest Laboratories; Industry
Eligibility: 18 Years and older
Enrollment: 680 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 17
States / cities: Buena Park, California • Hawaiian Gardens, California • Los Angeles, California + 14 more

Conditions: Multiple Myeloma
Interventions: Belantamab mafodotin, Lenalidomide, Dexamethasone, Bortezomib; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 12
States / cities: Birmingham, Alabama • Goodyear, Arizona • Atlanta, Georgia + 9 more

Conditions: Pregnancy Weight Gain, Postpartum Weight Retention, Childhood Obesity, Gestational Diabetes, Overweight and Obesity
Interventions: Healthy for Two/Healthy for You; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 534 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Aphakia, Presbyopia, Astigmatism
Interventions: ACRYSOF IQ RESTOR +3.0 Multifocal Toric IOL, ACRYSOF IQ RESTOR +2.5 D Multifocal Toric IOL, ACRYSOF IQ RESTOR +2.5 D Multifocal IOL, Cataract Surgery; Device · Procedure
Lead sponsor: Alcon Research; Industry
Eligibility: 22 Years and older
Enrollment: 2,449 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 37
States / cities: Dothan, Alabama • Phoenix, Arizona • Fresno, California + 32 more

Conditions: Drug Abuse
Interventions: Not listed
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 18 Years to 50 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2019
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Muscular Injury
Interventions: NUTRALYS pea protein supplement, Whey Protein, Apple juice; Dietary Supplement
Lead sponsor: Appalachian State University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Kannapolis, North Carolina

Conditions: Healthy
Interventions: Lidocaine topical system 1.8%; Drug
Lead sponsor: Scilex Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Dilworth, Minnesota

Conditions: Hereditary Angioedema
Interventions: Icatibant; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 5
States / cities: La Jolla, California • Los Angeles, California • Wheaton, Maryland + 2 more

Conditions: Respiratory Infection
Interventions: Vitamin D3 (cholecalciferol), Placebo Sugar Pill; Dietary Supplement
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 60 Years
Enrollment: 98 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Lung Cancer
Interventions: Bexarotene, Iressa; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Stanford, California

Conditions: Premature Labor, Pregnancy, Premature Birth
Interventions: Serial blood collection; Other
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years and older · Female only
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 6
States / cities: Birmingham, Alabama • Jackson, Mississippi • New York, New York + 3 more

Conditions: Endotracheal Intubation, Continuous IV Sedation, ICP Monitoring
Interventions: Standard-of-Care plus Dexmedetomidine, Standard-of-Care; Drug · Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Interstitial Cystitis
Interventions: Not listed
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years and older · Female only
Enrollment: 666 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Falls
Interventions: Pharmaceutical Care, Written Materials; Behavioral · Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 65 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Suicidal Ideation, Suicide, Attempted, Suicide and Self-harm, Non-suicidal Self-injury
Interventions: TEC-Sacredness, TEC-Control; Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 18 Years and older
Enrollment: 104 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Major Depressive Disorder
Interventions: Not listed
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 55 Years
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Cervical Dystonia
Interventions: Botulinum toxin type A; Biological
Lead sponsor: Ipsen; Industry
Eligibility: 18 Years and older
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 41
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Tucson, Arizona + 34 more

Conditions: Prostate Cancer
Interventions: focal cryotherapy; Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 21 Years and older · Male only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Trauma, Neurologic Deficits
Interventions: Pan-Computer Tomography; Procedure
Lead sponsor: Methodist Health System; Other
Eligibility: 18 Years and older
Enrollment: 510 participants
Timeline: 2020
U.S. locations: 1
States / cities: Dallas, Texas

Search by objective public record fields.

Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia

Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma

Duloxetine for the Treatment of Dysthymia

Poststroke Depression in Hemorrhagic Stroke

Improving Self Management Skills of Older Adults With Diabetes

Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections

To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

Pragmatic Randomized Clinical Trial to Limit Weight Gain in Pregnancy and Prevent Obesity

Post Approval Study of the AcrySof® IQ ReSTOR® Toric IOLs

The Effects of Expectation on Natural and Drug -Induced Rewards

Pea Protein Supplementation and Muscle Damage

Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% With Water Exposure

Efficacy, Safety and Tolerability of Icatibant for the Treatment of HAE

Human Lung Responses to Respiratory Pathogens

A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer

Indomethacin PK and PD Therapy in Pregnancy

Cerebral Perfusion Pressure Using Precedex and Other Sedatives

Assessing Chronic Pain Conditions in Patients (Pts) With and Without (w&wo) Interstitial Cystitis

Preventing Falls Through Enhanced Pharmaceutical Care

A Conditioning Paradigm to Increase Affinity for Sacredness of Life

Neuronal Responses to Social Feedback in Major Depressive Disorder

Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia

Study of Focal Cryoablation in Low-Risk Prostate Cancer

CT Change Management in Trauma Patients